Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000792

Type of data
NGS (Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
2.7 TB
File formats
  • BAM
  • GZIP
Research
hum0418
Date published
2025-04-09
Date modified
2025-04-25
DDBJ Search
JGAD000792 (opens in a new tab)
JGA Study
JGAS000662 (opens in a new tab)

Analysis method

Targeted DNA sequencing

Materials and participants
Cancer patient who will receive chemotherapy (ICD10: C00-D48): 507 cases 1018 samples
tumor tissues and non-tumor tissues (peripheral blood cells): 1018 samples
including 2 samples from 1 case having multiple cancers and 2 samples from 1 case having primary tumor and relapsed tumor
  • Health status
    Affected
  • Subject count
    507 (Individual)
Disease
Cancer patient who will receive chemotherapy
Sample description
DNA was extracted from tumor tissues and peripheral blood cells
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
NCC Oncopanel test (114 genes)
Reagent kit
KAPA Hyper Prep Kit
SureSelect XT Reagent Kit
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina MiSeq
Illumina NextSeq
Read type
Paired-end
Read length
151 bp
Reference genome
GRCh37
Data use policy
NBDC data sharing policy (JGAP000001)